Application of artificial intelligence (AI) in biomedical engineering technology is rapidly under development. The way AI applies in biomedical science is as the same as natural living cells consider playing the critical rules in their extracellular matrix environment. The present seminar is divided into two parts; in the first part I will discuss the basic principle of the AI technology. In the second part, I will discuss the recent applications of AI technology in healthcare. I will further show some of our recent project in which AI technology has been used in biomedical engineering including in cancer, diabetes, biosensor, and tissue engineering.
Dr. Hossein Hosseinkhani, Chemical Engineer, has 30 years of experience in biomedical engineering in both academia and industry in biomedical engineering research and development, which includes several years of basic science research experience in a number of premier institutions related to the structure and function of biomaterials, and in polymer-based medical implants development in the medical device industry. He is inventor of 22 International patents, several of which are licensed to companies acting in the biomedical fields and translated to 7 commercial products. He authored more than 100 scientific papers published on peer-reviewed Journals, 5 books (H-index: 46 Google Scholar). He is the founder of Matrix HT, Inc. a world leading biotech company dedicated to healthcare technology to improve patient's quality of life.